tiprankstipranks
Trending News
More News >

Satellos Bioscience Secures $40 Million Funding Boost

Story Highlights
Satellos Bioscience Secures $40 Million Funding Boost

Satellos Bioscience (TSE:MSCL) has released an update.

Confident Investing Starts Here:

Satellos Bioscience successfully closed a $40 million public offering, issuing over 63 million equity securities, to fund its Phase 2 clinical program for SAT-3247. The offering was led by Bloom Burton Securities Inc. and participated by several agents. The funds will support clinical development and general corporate needs.

For further insights into TSE:MSCL stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App